Conference Coverage
Conference Coverage
‘Unprecedented’ efficacy for daratumumab in rel/ref MM
CHICAGO—The addition of the monoclonal antibody daratumumab to bortezomib and dexamethasone, the current standard of care for relapsed/refractory...
Conference Coverage
Brentuximab vedotin boosted PET-negative rate in Hodgkin
Key clinical point: Brentuximab vedotin appears to eradicate residual disease after induction chemotherapy in a small study of patients with...
Conference Coverage
VIDEO: CPX-351 ‘new standard of care’ for older patients with secondary AML
Conference Coverage
Ethnic groups differ in BRCA risk management
Black, Hispanic, and white women differ in BRCA risk management.
Conference Coverage
Lenalidomide maintenance prolongs overall survival after ASCT
Lenalidomide maintenance therapy significantly prolonged overall survival after autologous stem cell transplant in newly diagnosed multiple...
Conference Coverage
Neoadjuvant chemo found to benefit locally advanced colon cancer
Treatment with neoadjuvant chemotherapy leads to significant downstaging in a selected group of patients with advanced colon cancer, results from...
Conference Coverage
Up-front ASCT superior for fit patients with newly diagnosed myeloma
Upfront high-dose melphalan and autologous stem cell transplantation was superior to bortezomib-melphalan-prednisone for fit patients under age 65...
Conference Coverage
Targeting vagal activity could improve breast cancer survival
Vagal activity predicts survival in patients with metastatic or recurrent breast cancer, a study found.
Conference Coverage
Few locally advanced cervical cancer patients get guideline-directed therapies
SAN DIEGO – Widespread nonadherence to NCCN guidelines spells shorter survival.
Conference Coverage
Dr. Matt Kalaycio’s top 10 hematologic oncology abstracts for ASCO 2016
Conference Coverage
Venetoclax achieves responses in CLL refractory to ibrutinib, idelalisib
Key clinical point: Venetoclax can achieve responses in patients who are refractory to ibrutinib. Major finding: The overall response rate was 61...